PDL BioPharma Inc. | Ownership
Companies that own PDL BioPharma Inc.
The Vanguard Group, Inc.
13,035,288
8.97%
667,805
0%
06/30/2018
Dimensional Fund Advisors LP
12,514,490
8.61%
996,690
0.01%
06/30/2018
BlackRock Fund Advisors
12,308,608
8.47%
-489,847
0%
06/30/2018
Renaissance Technologies LLC
9,688,354
6.66%
39,500
0.02%
06/30/2018
SSgA Funds Management, Inc.
8,216,760
5.65%
669,704
0%
06/30/2018
Connor, Clark & Lunn Investment Management Ltd.
5,677,647
3.91%
887,945
0.07%
06/30/2018
Northern Trust Investments, Inc.
4,954,468
3.41%
-19,480
0%
06/30/2018
AQR Capital Management LLC
4,291,443
2.95%
-535,662
0.01%
06/30/2018
Acadian Asset Management LLC
3,999,658
2.75%
-749,801
0.02%
06/30/2018
Charles Schwab Investment Management, Inc.
3,575,598
2.46%
142,413
0.01%
06/30/2018
| Address |
932 Southwood Boulevard
Incline Village Nevada 89451
United States
|
|
Employees
|
- |
| Website |
http://www.pdl.com |
| Updated |
07/08/2019 |
| PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. |
